# Evaluation of WATCHMAN Left Atrial Appendage Occlusion Device in Patients With Atrial Fibrillation Versus Rivaroxaban

Study · id `cardio:ct-nct02549963` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02549963](<https://clinicaltrials.gov/study/NCT02549963>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02549963

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT02549963. Randomized; no masking; primary purpose prevention. Start 2015-10 (registry gives no type); primary completion 2017-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT02549963, source copy `cardio:ctgov-nct02549963-2015-09-24`, retrieved 2026-10-26)
- Start date: 2015-10 (registry gives no type) (ClinicalTrials.gov record NCT02549963, source copy `cardio:ctgov-nct02549963-2015-09-24`, retrieved 2026-10-26)
- Primary completion: 2017-10 (anticipated) (ClinicalTrials.gov record NCT02549963, source copy `cardio:ctgov-nct02549963-2015-09-24`, retrieved 2026-10-26)
- Completion: Not reported
- Countries: China (ClinicalTrials.gov record NCT02549963, source copy `cardio:ctgov-nct02549963-2015-09-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02549963-2015-09-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of WATCHMAN Left Atrial Appendage Occlusion Device in Patients With Atrial Fibrillation Versus Rivaroxaban
- Condition: Atrial Fibrillation
- Condition: Stroke
- Intervention (Device): WATCHMAN Left Atrial Appendage Occlusion Device
- Intervention (Drug): Rivaroxaban
- Lead sponsor: Shulin Wu
- Lead sponsor class: OTHER
- Collaborator: Wuhan Asia Heart Hospital
- Collaborator class: OTHER
- Collaborator: Beijing Anzhen Hospital
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital, Sun Yat-Sen University
- Collaborator class: OTHER
- Collaborator: Second Affiliated Hospital of Guangzhou Medical University
- Collaborator class: OTHER
- Collaborator: The First Affiliated Hospital of Guangzhou Medical University
- Collaborator class: OTHER
- Collaborator: Guangdong Medical College
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital of Jinan University
- Collaborator class: OTHER
- Collaborator: Nanfang Hospital, Southern Medical University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Rivaroxaban (`cardio:rivaroxaban`)
- Registry lists this organization as a collaborator: Wuhan Asia Heart Hospital (`cardio:org-wuhan-asia-heart-hospital`)
- Registry lists this organization as a collaborator: Beijing Anzhen Hospital (`cardio:org-beijing-anzhen-hospital`)
- Registry lists this organization as a collaborator: First Affiliated Hospital, Sun Yat-Sen University (`cardio:org-first-affiliated-hospital-sun-yat-sen-university`)
- Registry lists this organization as a collaborator: Second Affiliated Hospital of Guangzhou Medical University (`cardio:org-second-affiliated-hospital-of-guangzhou-medical-university`)
- Registry lists this organization as a collaborator: The First Affiliated Hospital of Guangzhou Medical University (`cardio:org-the-first-affiliated-hospital-of-guangzhou-medical-cf91d6`)
- Registry lists this organization as a collaborator: First Affiliated Hospital of Jinan University (`cardio:org-first-affiliated-hospital-of-jinan-university`)
- Registry lists this organization as a collaborator: Nanfang Hospital, Southern Medical University (`cardio:org-nanfang-hospital-southern-medical-university`)

## Provenance

Content hash: 357f5b82b59b17424df7eaf8abdde3e39c807e39b770bfa14e41bdd15312150e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
